Carmat (CXT.MU)
| Previous close | 2.5600 |
| Open | 2.4700 |
| Bid | 2.3600 x N/A |
| Ask | 2.3900 x N/A |
| Day's range | 2.4700 - 2.4700 |
| 52-week range | 2.2600 - 7.9700 |
| Volume | |
| Avg. volume | 21 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 11 Sept 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireCARMAT Announces Updates in Its Governance
PARIS, June 25, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), announces the appointment of Mr. Pierre Bastid, Director, as Chairman of the Board of CARMAT, replacing Mr. Alexandre Conroy, who has resigned for personal reasons; and the retirement of Mr. André Muller, Director, foll
Business WireCARMAT Announces the Start of the Equitization of the First Tranche of Its EIB Loan
PARIS, June 13, 2024--Regulatory News: CARMAT (Paris:ALCAR):
- Business Wire
CARMAT Announces the Approval of All Resolutions Supported by the Board of Directors at Its Annual General Meeting
PARIS, May 30, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), informs its shareholders that the Combined General Meeting (AGM) held on May 30, 2024, was able to validly deliberate, the required quorum having been reached.
